WallStreetZenWallStreetZen

NASDAQ: NAUT
Nautilus Biotechnology Inc Stock Ownership - Who owns Nautilus Biotechnology?

Open Broker Account

Insider buying vs selling

Have Nautilus Biotechnology Inc insiders been buying or selling?
Buy
Sell
NameRoleDateSharesPriceValue
Subramanian SankarSenior VP Product Development2022-09-275,000$2.03
$10.15kBuy
Subramanian SankarSenior VP Product Development2022-09-2610,000$2.03
$20.25kBuy
Gwen E. WeldChief People Officer2022-09-2330,000$2.03
$60.78kBuy
Subramanian SankarSenior VP Product Development2022-09-1635,000$2.16
$75.46kBuy
Subramanian SankarSenior VP Product Development2022-09-1540,000$2.19
$87.76kBuy
Anna MowryCFO and Treasurer2022-08-1917,500$2.30
$40.22kBuy
Matthew B. MurphyGeneral Counsel2022-08-157,500$2.84
$21.31kBuy
Matthew B. MurphyGeneral Counsel2022-08-122,500$2.85
$7.13kBuy
Sujal M. PatelCEO President and Secretary2022-08-088,346$2.93
$24.45kBuy
Sujal M. PatelCEO President and Secretary2022-08-0541,654$2.92
$121.63kBuy

1 of 2

NAUT insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when NAUT insiders and whales buy or sell their stock.

NAUT Shareholders

What type of owners hold Nautilus Biotechnology Inc stock?
Institutional
Insider
Retail
NameHoldSharesValueType
Parag Mallick16.42%20,479,892$37.07MInsider
Ah Equity Partners Bio Ii LLC14.15%17,653,917$31.95MInsider
Vijay Satyanand Pande14.15%17,653,917$31.95MInsider
Sujal M. Patel13.72%17,108,999$30.97MInsider
Ah Equity Partners Bio Ii LLC13.07%16,298,006$29.50MInstitution
Perceptive Advisors LLC7.31%9,111,151$16.49MInstitution
Perceptive Advisors LLC7.31%9,111,151$16.49MInsider
Matthew S. McIlwain5.20%6,479,845$11.73MInsider
Madrona Venture Group LLC4.83%6,020,770$10.90MInstitution
Blackrock Inc2.57%3,209,494$5.81MInstitution

1 of 3

NAUT vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
NAUT38.34%61.66%Net BuyingNet Buying
MOLN2.83%0.00%
VYGR48.00%52.00%Net Selling
GRCL9.02%0.00%
SPRY27.90%72.10%Net BuyingNet Buying

Nautilus Biotechnology Stock Ownership FAQ

Who owns Nautilus Biotechnology?

Nautilus Biotechnology (NASDAQ: NAUT) is owned by 45.25% institutional shareholders, 72.77% Nautilus Biotechnology insiders, and 0.00% retail investors. Parag Mallick is the largest individual Nautilus Biotechnology shareholder, owning 20.48M shares representing 16.42% of the company. Parag Mallick's Nautilus Biotechnology shares are currently valued at $37.27M.

If you're new to stock investing, here's how to buy Nautilus Biotechnology stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.